XML 20 R9.htm IDEA: XBRL DOCUMENT v3.25.3
Revenue Recognition
9 Months Ended
Sep. 30, 2025
Revenue from Contract with Customer [Abstract]  
Revenue Recognition Revenue Recognition
Contract Balances
Unearned revenue primarily relates to revenue that is recognized over time for one-year software license contracts. Approximately $98 million and $477 million of the December 31, 2024 balance was recognized as revenue during the three and nine months ended September 30, 2025, while approximately $110 million and $500 million of the December 31, 2023 balance was recognized as revenue during the three and nine months ended September 30, 2024.
Operating Lease Revenue
Sales of software and rental includes rental revenue from durable medical devices as part of operating lease arrangements (reported within the MedSurg segment), which was $157 million and $456 million for the three and nine months ended September 30, 2025, and $148 million and $442 million for the three and nine months ended September 30, 2024.
Customer Concentration
No customer accounted for more than 10% of the Company’s revenues for the three and nine months ended September 30, 2025 or 2024. Additionally, no customers accounted for more than 10% of accounts receivable as of September 30, 2025 or December 31, 2024.
Revenue Recognition Revenue Recognition
Contract Balances
Unearned revenue primarily relates to revenue that is recognized over time for one-year software license contracts. Approximately $98 million and $477 million of the December 31, 2024 balance was recognized as revenue during the three and nine months ended September 30, 2025, while approximately $110 million and $500 million of the December 31, 2023 balance was recognized as revenue during the three and nine months ended September 30, 2024.
Operating Lease Revenue
Sales of software and rental includes rental revenue from durable medical devices as part of operating lease arrangements (reported within the MedSurg segment), which was $157 million and $456 million for the three and nine months ended September 30, 2025, and $148 million and $442 million for the three and nine months ended September 30, 2024.
Customer Concentration
No customer accounted for more than 10% of the Company’s revenues for the three and nine months ended September 30, 2025 or 2024. Additionally, no customers accounted for more than 10% of accounts receivable as of September 30, 2025 or December 31, 2024.